3 article(s) from Saito, Norimichi
Graphical Abstract
Figure 1: Ratios of CF3-containing drugs in marketed fluoro-pharmaceuticals and registered fluoro-agrochemica...
Figure 2: Selected examples of CF3-containing biologically active molecules.
Scheme 1: Transformation of acyl fluorides to trifluoromethyl compounds. a) Deoxyfluorination of acyl fluorid...
Scheme 2: The substrate scope of acyl fluorides. Reaction conditions: 1 (0.3 mmol), FLUOLEAD® (0.9 mmol, 3.0 ...
Scheme 3: Mechanism of deoxyfluorination of acyl fluorides 1 with FLUOLEAD®/Olah’s reagent to trifluoromethyl...
Graphical Abstract
Figure 1: Compounds used for the biological study.
Figure 2: Compounds 1–4 induced cell death in U937 cells. Briefly, U937 cells (1 × 104 cells/mL) were incubat...
Scheme 1: Synthesis of pentafluoro-(2-iodophenyl)-λ6-sulfane (7).
Scheme 2: Synthesis of unsymmetrical ortho-SF5 diaryliodonium salts 3p, 4b, 5a and 6a.
Figure 3: X-ray crystallographic structure of 3p drawn at 50% probability (CCDC 1573953).
Figure 4: Ortho-SF5 phenyl iodonium salts 3p and 5a and their structural components 7 and 9 induced cell deat...
Figure 5: 3k, 3m and 3p induced cell death in AGLCL, a human normal B cell line. Briefly, AGLCL cells (1 × 104...
Graphical Abstract
Scheme 1: Preparation of ArSF4Cl 2.
Scheme 2: Preparation of Ar(SF4Cl)n from Ar(SH)n (n = 2, 3).
Scheme 3: Reaction mechanism for the formation of ArSF4Cl.
Scheme 4: Reaction mechanism for the formation of trans and cis-ArSF4Cl.
Scheme 5: Preparation of ArSF5 with ZnF2.
Scheme 6: Preparation of PhSF5 with anhydrous HF.
Scheme 7: Preparation of 3a with HF–pyridine.
Scheme 8: Preparation of polyfluorinated ArSF5.
Scheme 9: Preparation of aryl bis- and tris(sulfur pentafluorides), Ar(SF5)n (n = 2,3).